CME Group Inc. (NASDAQ:CME) Director Martin J. Gepsman sold 200 shares of the business’s stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $126.14, for a total transaction of $25,228.00. Following the completion of the transaction, the director now owns 43,311 shares of the company’s stock, valued at $5,463,249.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of CME Group Inc. (CME) traded down 0.44% during midday trading on Friday, reaching $123.64. The company had a trading volume of 271,946 shares. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $127.96. The stock has a market capitalization of $42.03 billion, a PE ratio of 25.24 and a beta of 0.73. The company’s 50 day moving average price is $123.43 and its 200 day moving average price is $120.91.

CME Group (NASDAQ:CME) last announced its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. During the same period last year, the business posted $1.14 EPS. The company’s revenue was up 2.1% on a year-over-year basis. Equities research analysts expect that CME Group Inc. will post $4.81 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.13%. CME Group’s dividend payout ratio (DPR) is currently 53.99%.

ILLEGAL ACTIVITY NOTICE: “CME Group Inc. (NASDAQ:CME) Director Sells $25,228.00 in Stock” was first reported by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/11/cme-group-inc-nasdaqcme-director-sells-25228-00-in-stock.html.

Several hedge funds have recently bought and sold shares of CME. RMB Capital Management LLC increased its stake in CME Group by 3.1% in the first quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after buying an additional 3,501 shares during the period. Profund Advisors LLC increased its stake in CME Group by 4.2% in the first quarter. Profund Advisors LLC now owns 11,222 shares of the financial services provider’s stock worth $1,333,000 after buying an additional 457 shares during the period. Thrivent Financial For Lutherans increased its stake in CME Group by 5.6% in the first quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock worth $1,485,000 after buying an additional 660 shares during the period. Parsons Capital Management Inc. RI acquired a new stake in CME Group during the first quarter worth $569,000. Finally, Dowling & Yahnke LLC increased its stake in CME Group by 1.7% in the first quarter. Dowling & Yahnke LLC now owns 6,844 shares of the financial services provider’s stock worth $813,000 after buying an additional 114 shares during the period. Hedge funds and other institutional investors own 83.29% of the company’s stock.

A number of equities research analysts have recently weighed in on the company. UBS AG restated a “buy” rating and set a $134.00 price target (down previously from $136.00) on shares of CME Group in a research note on Monday, June 5th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Keefe, Bruyette & Woods restated a “hold” rating and set a $127.00 price target on shares of CME Group in a research note on Friday, July 14th. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Finally, Deutsche Bank AG dropped their price target on CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a research note on Tuesday, July 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $131.63.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.